Catalyst Wire Dossier Catalyst Wire Dossier

Gylden nanoparticle-based peptide vaccine

· Gylden Pharma Ltd
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Gylden nanoparticle-based peptide vaccine, covering 2025-02-12 to 2025-02-12. Get the full timeline:

Most recent: Clinical Trial Update: A Phase-I Study of a Nanoparticle-based Peptide Vaccine Against SARS-CoV-2 [Phase 1]

See pricing